Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold et al., Positional cloning of the mouse obese gene and its human homologue, Nature, vol.372, issue.6505, pp.425-432, 1994.
DOI : 10.1038/372425a0

I. S. Farooqi, S. A. Jebb, G. Langmack, E. Lawrence, C. H. Cheetham et al., Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency, New England Journal of Medicine, vol.341, issue.12, pp.341-879, 1999.
DOI : 10.1056/NEJM199909163411204

E. A. Oral, V. Simha, E. Ruiz, A. Andewelt, A. Premkumar et al., Leptin-Replacement Therapy for Lipodystrophy, New England Journal of Medicine, vol.346, issue.8, pp.346-570, 2002.
DOI : 10.1056/NEJMoa012437

S. B. Heymsfield, A. S. Greenberg, K. Fujioka, R. M. Dixon, R. Kushner et al., Recombinant Leptin for Weight Loss in Obese and Lean Adults, JAMA, vol.282, issue.16, pp.1568-1575, 1999.
DOI : 10.1001/jama.282.16.1568

J. B. Barnett and S. Prins, Congenital leptin deficiency is associated with severe early-onset obesity in humans, Nature, vol.387, pp.903-908, 1997.

J. L. Halaas, K. S. Gajiwala, M. Maffei, S. L. Cohen, B. T. Chait et al., Weight-reducing effects of the plasma protein encoded by the obese gene, Science, vol.269, issue.5223, pp.543-546, 1995.
DOI : 10.1126/science.7624777

M. A. Pelleymounter, M. J. Cullen, M. B. Baker, R. Hecht, D. Winters et al., Effects of the obese gene product on body weight regulation in ob/ob mice, Science, vol.269, issue.5223, pp.540-543, 1995.
DOI : 10.1126/science.7624776

I. S. Farooqi, Leptin and the Onset of Puberty: Insights from Rodent and Human Genetics, Seminars in Reproductive Medicine, vol.20, issue.2, pp.139-144, 2002.
DOI : 10.1055/s-2002-32505

J. Licinio, S. Caglayan, M. Ozata, B. O. Yildiz, P. B. De-miranda et al., Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults, Proc. Natl. Acad. Sci. U. S. A. 101, pp.4531-4536, 2004.
DOI : 10.1073/pnas.0308767101

G. Paz-filho, M. L. Wong, and J. Licinio, Ten years of leptin replacement therapy, Obesity Reviews, vol.41, issue.5, pp.315-323, 2011.
DOI : 10.1111/j.1467-789X.2010.00840.x

V. P. Andreev, R. C. Dwivedi, G. Paz-filho, O. V. Krokhin, M. L. Wong et al., Dynamics of plasma proteome during leptin-replacement therapy in genetically based leptin deficiency, The Pharmacogenomics Journal, vol.7, issue.3, pp.174-190, 2011.
DOI : 10.1152/ajpendo.90450.2008

I. S. Farooqi, E. Bullmore, J. Keogh, J. Gillard, S. O-'rahilly et al., Leptin Regulates Striatal Regions and Human Eating Behavior, Leptin regulates striatal regions and human eating behavior, p.1355, 2007.
DOI : 10.1126/science.1144599

K. Baicy, E. D. London, J. Monterosso, M. L. Wong, T. Delibasi et al., Leptin replacement alters brain response to food cues in genetically leptin-deficient adults, Proceedings of the National Academy of Sciences, vol.104, issue.46, pp.18276-18279, 2007.
DOI : 10.1073/pnas.0706481104

S. Frank, M. Heni, A. Moss, J. Von-schnurbein, A. Fritsche et al., Leptin Therapy in a Congenital Leptin-Deficient Patient Leads to Acute and Long-Term Changes in Homeostatic, Reward, and Food-Related Brain Areas, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.8, pp.96-1283, 2011.
DOI : 10.1210/jc.2010-2713

W. T. Gibson, I. S. Farooqi, M. Moreau, A. M. Depaoli, E. Lawrence et al., Congenital leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy, J. Clin. Endocrinol. Metab, pp.89-4821, 2004.

J. E. Galgani, F. L. Greenway, S. Caglayan, M. L. Wong, J. Licinio et al., Leptin replacement prevents weight loss-induced metabolic adaptation in congenital leptindeficient patients, J. Clin. Endocrinol. Metab, pp.95-851, 2010.

V. P. Andreev, G. Paz-filho, M. L. Wong, and J. Licinio, Deconvolution of Insulin Secretion, Insulin Hepatic Extraction Post-hepatic Delivery Rates and Sensitivity during 24-hour Standardized Meals: Time Course of Glucose Homeostasis in Leptin Replacement Treatment, Hormone and Metabolic Research, vol.41, issue.02, pp.41-142, 2009.
DOI : 10.1055/s-0028-1082048

G. Paz-filho, K. Esposito, B. Hurwitz, A. Sharma, C. Dong et al., Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients, AJP: Endocrinology and Metabolism, vol.295, issue.6, pp.295-1401, 2008.
DOI : 10.1152/ajpendo.90450.2008

C. S. Mantzoros, M. Ozata, A. B. Negrao, M. A. Suchard, M. Ziotopoulou et al., Synchronicity of Frequently Sampled Thyrotropin (TSH) and Leptin Concentrations in Healthy Adults and Leptin-Deficient Subjects: Evidence for Possible Partial TSH Regulation by Leptin in Humans, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.7, pp.3284-3291, 2001.
DOI : 10.1210/jcem.86.7.7644

K. Hedbacker, K. Birsoy, R. W. Wysocki, E. Asilmaz, R. S. Ahima et al., Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene, Cell Metabolism, vol.11, issue.1, pp.11-22, 2010.
DOI : 10.1016/j.cmet.2009.11.007

A. Garg, Lipodystrophies: Genetic and Acquired Body Fat Disorders, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.11, pp.3313-3325, 2011.
DOI : 10.1210/jc.2011-1159

C. Vigouroux, M. Caron-debarle, C. Le-dour, J. Magre, and J. Capeau, Molecular mechanisms of human lipodystrophies: From adipocyte lipid droplet to oxidative stress and lipotoxicity, The International Journal of Biochemistry & Cell Biology, vol.43, issue.6, pp.43-862, 2011.
DOI : 10.1016/j.biocel.2011.03.002

I. Shimomura, R. E. Hammer, S. Ikemoto, M. S. Brown, and J. L. Goldstein, Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy, Nature, vol.401, pp.73-76, 1999.

C. Colombo, J. J. Cutson, T. Yamauchi, C. Vinson, T. Kadowaki et al., Transplantation of Adipose Tissue Lacking Leptin Is Unable to Reverse the Metabolic Abnormalities Associated With Lipoatrophy, Diabetes, vol.51, issue.9, pp.2727-2733, 2002.
DOI : 10.2337/diabetes.51.9.2727

K. F. Petersen, E. A. Oral, S. Dufour, D. Befroy, C. Ariyan et al., Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy, Journal of Clinical Investigation, vol.109, issue.10, pp.1345-1350, 2002.
DOI : 10.1172/JCI0215001

V. Simha, L. S. Szczepaniak, A. J. Wagner, A. M. Depaoli, and A. Garg, Effect of Leptin Replacement on Intrahepatic and Intramyocellular Lipid Content in Patients With Generalized Lipodystrophy, Diabetes Care, vol.26, issue.1, pp.30-35, 2003.
DOI : 10.2337/diacare.26.1.30

R. H. Unger, G. O. Clark, P. E. Scherer, and L. Orci, Lipid homeostasis, lipotoxicity and the metabolic syndrome, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1801, issue.3, pp.209-214, 2010.
DOI : 10.1016/j.bbalip.2009.10.006

G. I. Shulman, Cellular mechanisms of insulin resistance, Journal of Clinical Investigation, vol.106, issue.2, pp.171-176, 2000.
DOI : 10.1172/JCI10583

Y. Minokoshi, Y. B. Kim, O. D. Peroni, L. G. Fryer, C. Muller et al., Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase, Nature, vol.415, issue.6869, pp.339-343, 2002.
DOI : 10.1038/415339a

A. Y. Chong, B. C. Lupsa, E. K. Cochran, and P. Gorden, Efficacy of leptin therapy in the different forms of human lipodystrophy, Diabetologia, vol.110, issue.Suppl 2, pp.27-35, 2010.
DOI : 10.1007/s00125-009-1502-9

P. Cohen and J. M. Friedman, Leptin and the control of metabolism: role for stearoyl-CoA desaturase-1 (SCD-1), J. Nutr, vol.134, pp.2455-2463, 2004.

W. A. Haque, I. Shimomura, Y. Matsuzawa, and A. Garg, Serum Adiponectin and Leptin Levels in Patients with Lipodystrophies, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.5, p.2395, 2002.
DOI : 10.1210/jcem.87.5.8624

J. R. Mcduffie, P. A. Riggs, K. A. Calis, R. J. Freedman, E. A. Oral et al., Effects of Exogenous Leptin on Satiety and Satiation in Patients with Lipodystrophy and Leptin Insufficiency, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.9, pp.89-4258, 2004.
DOI : 10.1210/jc.2003-031868

K. Ebihara, H. Masuzaki, and K. Nakao, Long-Term Leptin-Replacement Therapy for Lipoatrophic Diabetes, New England Journal of Medicine, vol.351, issue.6, pp.615-616, 2004.
DOI : 10.1056/NEJM200408053510623

E. D. Javor, E. K. Cochran, C. Musso, J. R. Young, A. M. Depaoli et al., Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy, Diabetes, vol.54, issue.7, 1994.
DOI : 10.2337/diabetes.54.7.1994

E. D. Javor, M. G. Ghany, E. K. Cochran, E. A. Oral, A. M. Depaoli et al., Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy, Hepatology, vol.278, issue.4, pp.753-760, 2005.
DOI : 10.1002/hep.20672

E. D. Javor, S. A. Moran, J. R. Young, E. K. Cochran, A. M. Depaoli et al., Proteinuric Nephropathy in Acquired and Congenital Generalized Lipodystrophy: Baseline Characteristics and Course during Recombinant Leptin Therapy, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.7, pp.3199-3207, 2004.
DOI : 10.1210/jc.2003-032140

K. Ebihara, T. Kusakabe, M. Hirata, H. Masuzaki, F. Miyanaga et al., Efficacy and Safety of Leptin-Replacement Therapy and Possible Mechanisms of Leptin Actions in Patients with Generalized Lipodystrophy, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.2, pp.92-532, 2007.
DOI : 10.1210/jc.2006-1546

J. A. Yiannias, D. J. Dicaudo, and E. Maskin, Peripheral T-cell lymphoma presenting as lipoatrophy and nodules, International Journal of Dermatology, vol.18, issue.12, pp.1415-1419, 2006.
DOI : 10.1067/mjd.2003.45

E. A. Oral, E. D. Javor, L. Ding, G. Uzel, E. K. Cochran et al., Leptin Replacement Therapy Modulates Circulating Lymphocyte Subsets and Cytokine Responsiveness in Severe Lipodystrophy, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.2, pp.91-621, 2006.
DOI : 10.1210/jc.2005-1220

S. A. Moran, N. Patten, J. R. Young, E. Cochran, N. Sebring et al., Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy, Metabolism, vol.53, issue.4, pp.53-513, 2004.
DOI : 10.1016/j.metabol.2003.10.019

V. Simha, J. E. Zerwekh, K. Sakhaee, and A. Garg, Effect of Subcutaneous Leptin Replacement Therapy on Bone Metabolism in Patients with Generalized Lipodystrophy, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.11, pp.4942-4945, 2002.
DOI : 10.1210/jc.2002-020792

E. A. Oral, E. Ruiz, A. Andewelt, N. Sebring, A. J. Wagner et al., Effect of Leptin Replacement on Pituitary Hormone Regulation in Patients with Severe Lipodystrophy, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.7, pp.3110-3117, 2002.
DOI : 10.1210/jcem.87.7.8591

C. Musso, E. Cochran, E. Javor, J. Young, A. M. Depaoli et al., The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients, Metabolism, vol.54, issue.2, pp.54-255, 2005.
DOI : 10.1016/j.metabol.2004.08.021

A. O. Lungu, E. Safar-zadeh, A. Goodling, E. Cochran, and P. Gorden, Insulin Resistance Is a Sufficient Basis for Hyperandrogenism in Lipodystrophic Women with Polycystic Ovarian Syndrome, J. Clin. Endocrinol. Metab, 2011.

J. Beltrand, M. Beregszaszi, D. Chevenne, G. Sebag, M. D. Kerdanet et al., Metabolic Correction Induced by Leptin Replacement Treatment in Young Children With Berardinelli-Seip Congenital Lipoatrophy, PEDIATRICS, vol.120, issue.2, pp.291-296, 2007.
DOI : 10.1542/peds.2006-3165

J. Beltrand, N. Lahlou, T. Le-charpentier, G. Sebag, S. Leka et al., Resistance to leptin-replacement therapy in Berardinelli-Seip congenital lipodystrophy: an immunological origin, European Journal of Endocrinology, vol.162, issue.6, pp.1083-1091, 2010.
DOI : 10.1530/EJE-09-1027

J. Y. Park, E. D. Javor, E. K. Cochran, A. M. Depaoli, and P. Gorden, Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy, Metabolism, vol.56, issue.4, pp.56-508, 2007.
DOI : 10.1016/j.metabol.2006.11.010

J. M. Guettier, J. Y. Park, E. K. Cochran, C. Poitou, A. Basdevant et al., Leptin therapy for partial lipodystrophy linked to a PPARgamma mutation, Clin. Endocrinol. (Oxf), pp.68-547, 2008.

J. Y. Park, A. Y. Chong, E. K. Cochran, D. E. Kleiner, M. J. Haller et al., Type 1 Diabetes Associated with Acquired Generalized Lipodystrophy and Insulin Resistance: The Effect of Long-Term Leptin Therapy, The Journal of Clinical Endocrinology & Metabolism, vol.93, issue.1, pp.93-119, 2008.
DOI : 10.1210/jc.2007-1856

E. A. Oral and J. L. Chan, Rationale for Leptin-Replacement Therapy for Severe Lipodystrophy, Endocrine Practice, vol.16, issue.2, pp.324-333, 2010.
DOI : 10.4158/EP09155.RA

D. B. Savage and S. , Leptin therapy in lipodystrophy, Diabetologia, vol.29, issue.1, pp.7-9, 2010.
DOI : 10.1007/s00125-009-1545-y

M. Caron-debarle, C. Lagathu, F. Boccara, C. Vigouroux, and J. Capeau, HIV-associated lipodystrophy: from fat injury to premature aging, Trends in Molecular Medicine, vol.16, issue.5, pp.218-229, 2010.
DOI : 10.1016/j.molmed.2010.03.002

F. Villarroya, P. Domingo, and M. Giralt, Drug-induced lipotoxicity: Lipodystrophy associated with HIV-1 infection and antiretroviral treatment, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1801, issue.3, pp.392-399, 2010.
DOI : 10.1016/j.bbalip.2009.09.018

J. H. Lee, J. L. Chan, E. Sourlas, V. Raptopoulos, and C. S. Mantzoros, Recombinant Methionyl Human Leptin Therapy in Replacement Doses Improves Insulin Resistance and Metabolic Profile in Patients with Lipoatrophy and Metabolic Syndrome Induced by the Highly Active Antiretroviral Therapy, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.7, pp.91-2605, 2006.
DOI : 10.1210/jc.2005-1545

K. Mulligan, H. Khatami, J. M. Schwarz, G. K. Sakkas, A. M. Depaoli et al., The Effects of Recombinant Human Leptin on Visceral Fat, Dyslipidemia, and Insulin Resistance in Patients with Human Immunodeficiency Virus-Associated Lipoatrophy and Hypoleptinemia, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.4, pp.94-1137, 2009.
DOI : 10.1210/jc.2008-1588

F. Magkos, A. Brennan, L. Sweeney, E. S. Kang, J. Doweiko et al., Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus???infected lipoatrophic men treated with pioglitazone: a pilot study, Metabolism, vol.60, issue.7, pp.60-1045, 2011.
DOI : 10.1016/j.metabol.2010.10.002

A. M. Brennan, J. H. Lee, S. Tsiodras, J. L. Chan, J. Doweiko et al., r-metHuLeptin improves highly active antiretroviral therapy-induced lipoatrophy and the metabolic syndrome, but not through altering circulating IGF and IGF-binding protein levels: observational and interventional studies in humans, European Journal of Endocrinology, vol.160, issue.2, pp.173-176, 2009.
DOI : 10.1530/EJE-08-0597

C. K. Welt, J. L. Chan, J. Bullen, R. Murphy, P. Smith et al., Recombinant human leptin in women with hypothalamic amenorrhea, N. Engl. J. Med, pp.351-987, 2004.

S. H. Chou, J. P. Chamberland, X. Liu, G. Matarese, C. Gao et al., Leptin is an effective treatment for hypothalamic amenorrhea, Proceedings of the National Academy of Sciences, vol.108, issue.16, pp.6585-6590, 2011.
DOI : 10.1073/pnas.1015674108

E. Sienkiewicz, F. Magkos, K. N. Aronis, M. Brinkoetter, J. P. Chamberland et al., Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women, Metabolism, vol.60, issue.9, pp.60-1211, 2011.
DOI : 10.1016/j.metabol.2011.05.016

M. G. Myers, M. A. Cowley, and H. Munzberg, Mechanisms of Leptin Action and Leptin Resistance, Annual Review of Physiology, vol.70, issue.1, pp.537-556, 2008.
DOI : 10.1146/annurev.physiol.70.113006.100707

J. C. Won, P. G. Jang, C. Namkoong, E. H. Koh, S. K. Kim et al., Central Administration of an Endoplasmic Reticulum Stress Inducer Inhibits the Anorexigenic Effects of Leptin and Insulin, Obesity, vol.64, issue.10, pp.1861-1865, 2009.
DOI : 10.1038/oby.2009.194

H. S. Moon, G. Matarese, A. M. Brennan, J. P. Chamberland, X. Liu et al., Efficacy of Metreleptin in Obese Patients With Type 2 Diabetes: Cellular and Molecular Pathways Underlying Leptin Tolerance, Diabetes, vol.60, issue.6, pp.1647-1656, 2011.
DOI : 10.2337/db10-1791

L. Ozcan, A. S. Ergin, A. Lu, J. Chung, S. Sarkar et al., Endoplasmic reticulum stress plays a central role in development of leptin resistance, Cell Metab, pp.35-51, 2009.

J. D. Roth, B. L. Roland, R. L. Cole, J. L. Trevaskis, C. Weyer et al., Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies, Proceedings of the National Academy of Sciences, vol.105, issue.20, pp.7257-7262, 2008.
DOI : 10.1073/pnas.0706473105

E. Ravussin, S. R. Smith, J. A. Mitchell, R. Shringarpure, K. Shan et al., Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy, Obesity, vol.355, issue.1, pp.1736-1743, 2009.
DOI : 10.1038/oby.2009.184

M. Rosenbaum, R. Goldsmith, D. Bloomfield, A. Magnano, L. Weimer et al., Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight, Journal of Clinical Investigation, vol.115, issue.12, pp.115-3579, 2005.
DOI : 10.1172/JCI25977DS1

N. Chinookoswong, J. L. Wang, and Z. Q. Shi, Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat, Diabetes, vol.48, issue.7, pp.1487-1492, 1999.
DOI : 10.2337/diabetes.48.7.1487

F. Miyanaga, Y. Ogawa, K. Ebihara, S. Hidaka, T. Tanaka et al., Leptin as an adjunct of insulin therapy in insulin-deficient diabetes, Diabetologia, vol.46, issue.10, pp.1329-1337, 2003.
DOI : 10.1007/s00125-003-1193-6

X. Yu, B. H. Park, M. Y. Wang, Z. V. Wang, and R. H. Unger, Making insulin-deficient type 1 diabetic rodents thrive without insulin, Proceedings of the National Academy of Sciences, vol.105, issue.37, pp.14070-14075, 2008.
DOI : 10.1073/pnas.0806993105

M. Y. Wang, L. Chen, G. O. Clark, Y. Lee, R. D. Stevens et al., Leptin therapy in insulin-deficient type I diabetes, Proceedings of the National Academy of Sciences, vol.107, issue.11, pp.4813-4819, 2010.
DOI : 10.1073/pnas.0909422107

A. J. Kruger, C. Yang, K. L. Lipson, S. C. Pino, J. H. Leif et al., Leptin treatment confers clinical benefit at multiple stages of virally induced type 1 diabetes in BB rats, Autoimmunity, vol.52, issue.2, pp.137-148, 2011.
DOI : 10.4049/jimmunol.166.10.5909

T. Kusakabe, H. Tanioka, K. Ebihara, M. Hirata, L. Miyamoto et al., Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet, Diabetologia, vol.109, issue.4, pp.675-683, 2009.
DOI : 10.1007/s00125-009-1258-2

S. P. Kalra, Central leptin gene therapy ameliorates diabetes type 1 and 2 through two independent hypothalamic relays; a benefit beyond weight and appetite regulation, Peptides, vol.30, issue.10, pp.1957-1963, 2009.
DOI : 10.1016/j.peptides.2009.07.021

D. Accili, A. Cama, F. Barbetti, H. Kadowaki, T. Kadowaki et al., Insulin resistance due to mutations of the insulin receptor gene: An overview, Journal of Endocrinological Investigation, vol.66, issue.11, pp.15-857, 1992.
DOI : 10.1007/BF03348820

E. Cochran, J. R. Young, N. Sebring, A. Depaoli, E. A. Oral et al., Efficacy of Recombinant Methionyl Human Leptin Therapy for the Extreme Insulin Resistance of the Rabson-Mendenhall Syndrome, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.4, pp.89-1548, 2004.
DOI : 10.1210/jc.2003-031952

N. Yamada, G. Katsuura, Y. Ochi, K. Ebihara, T. Kusakabe et al., Impaired CNS Leptin Action Is Implicated in Depression Associated with Obesity, Endocrinology, vol.152, issue.7, pp.2634-2643, 2011.
DOI : 10.1210/en.2011-0004

G. E. Miller, K. E. Freedland, R. M. Carney, C. A. Stetler, and W. A. Banks, Pathways linking depression, adiposity, and inflammatory markers in healthy young adults, Brain, Behavior, and Immunity, vol.17, issue.4, pp.17-276, 2003.
DOI : 10.1016/S0889-1591(03)00057-6

E. D. London, S. M. Berman, S. Chakrapani, T. Delibasi, J. Monterosso et al., Short-Term Plasticity of Gray Matter Associated with Leptin Deficiency and Replacement, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.8, pp.96-1212, 2011.
DOI : 10.1210/jc.2011-0314

N. Tezapsidis, J. M. Johnston, M. A. Smith, J. W. Ashford, G. Casadesus et al., Leptin: A Novel Therapeutic Strategy for Alzheimer's Disease, Journal of Alzheimer's Disease, vol.16, issue.4, pp.731-740, 2009.
DOI : 10.3233/JAD-2009-1021

S. J. Greco, A. Hamzelou, J. M. Johnston, M. A. Smith, J. W. Ashford et al., Leptin boosts cellular metabolism by activating AMPK and the sirtuins to reduce tau phosphorylation and beta-amyloid in neurons, Biochem. Biophys. Res. Commun, pp.414-170, 2011.

T. Olsson, B. Nasman, S. Rasmuson, and B. Ahren, Dual relation between leptin and cortisol in humans is disturbed in Alzheimer's disease, Biol. Psychiatry, vol.44, pp.374-376, 1998.

D. A. Power, J. Noel, R. Collins, and D. , Circulating Leptin Levels and Weight Loss in Alzheimer???s Disease Patients, Dementia and Geriatric Cognitive Disorders, vol.12, issue.2, pp.12-167, 2001.
DOI : 10.1159/000051252

K. F. Holden, K. Lindquist, F. A. Tylavsky, C. Rosano, T. B. Harris et al., Serum leptin level and cognition in the elderly: Findings from the Health ABC Study, Neurobiology of Aging, vol.30, issue.9, pp.1483-1489, 2009.
DOI : 10.1016/j.neurobiolaging.2007.11.024

W. Lieb, A. S. Beiser, R. S. Vasan, Z. S. Tan, R. Au et al., Association of Plasma Leptin Levels With Incident Alzheimer Disease and MRI Measures of Brain Aging, JAMA, vol.302, issue.23, pp.302-2565, 2009.
DOI : 10.1001/jama.2009.1836

J. M. Johnston, S. J. Greco, A. Hamzelou, J. W. Ashford, and N. Tezapsidis, Repositioning leptin as a therapy for Alzheimer???s disease, Therapy, vol.8, issue.5, pp.481-490, 2011.
DOI : 10.2217/thy.11.57